IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 155 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $650,559 | -24.5% | 74,691 | -0.9% | 0.00% | -50.0% |
Q4 2023 | $862,084 | +17.8% | 75,357 | -0.8% | 0.00% | -20.0% |
Q3 2023 | $731,697 | -7.4% | 75,981 | +2.3% | 0.01% | 0.0% |
Q2 2023 | $789,892 | +0.9% | 74,238 | -0.2% | 0.01% | 0.0% |
Q1 2023 | $782,825 | -14.7% | 74,413 | +0.5% | 0.01% | -16.7% |
Q4 2022 | $917,579 | +18.7% | 74,058 | -0.8% | 0.01% | 0.0% |
Q3 2022 | $773,000 | -10.9% | 74,624 | -0.9% | 0.01% | 0.0% |
Q2 2022 | $868,000 | -5.3% | 75,319 | +3.3% | 0.01% | +20.0% |
Q1 2022 | $917,000 | +0.8% | 72,878 | -6.6% | 0.01% | 0.0% |
Q4 2021 | $910,000 | -12.3% | 78,007 | -1.9% | 0.01% | -16.7% |
Q3 2021 | $1,038,000 | -1.0% | 79,515 | -2.3% | 0.01% | +50.0% |
Q2 2021 | $1,048,000 | -23.8% | 81,404 | -33.8% | 0.00% | -20.0% |
Q1 2021 | $1,375,000 | -4.7% | 122,973 | -2.9% | 0.01% | 0.0% |
Q4 2020 | $1,443,000 | +68.2% | 126,704 | +32.8% | 0.01% | +25.0% |
Q3 2020 | $858,000 | -14.8% | 95,422 | -2.2% | 0.00% | -20.0% |
Q2 2020 | $1,007,000 | +7.9% | 97,592 | +5.5% | 0.01% | 0.0% |
Q1 2020 | $933,000 | -27.2% | 92,491 | -3.9% | 0.01% | 0.0% |
Q4 2019 | $1,281,000 | +53.8% | 96,237 | -0.8% | 0.01% | +66.7% |
Q3 2019 | $833,000 | -22.1% | 97,046 | -0.7% | 0.00% | -25.0% |
Q2 2019 | $1,069,000 | -11.9% | 97,723 | +8.9% | 0.00% | -20.0% |
Q1 2019 | $1,214,000 | +26.5% | 89,710 | -3.1% | 0.01% | +25.0% |
Q4 2018 | $960,000 | -43.4% | 92,618 | +0.8% | 0.00% | -33.3% |
Q3 2018 | $1,697,000 | -1.7% | 91,906 | +1.8% | 0.01% | 0.0% |
Q2 2018 | $1,726,000 | +30.0% | 90,250 | +4.8% | 0.01% | +20.0% |
Q1 2018 | $1,328,000 | -2.4% | 86,090 | -5.1% | 0.01% | +25.0% |
Q4 2017 | $1,360,000 | -4.5% | 90,721 | +0.5% | 0.00% | -20.0% |
Q3 2017 | $1,424,000 | -9.7% | 90,291 | +8.1% | 0.01% | -16.7% |
Q2 2017 | $1,577,000 | +18.0% | 83,540 | +6.6% | 0.01% | +20.0% |
Q1 2017 | $1,337,000 | +17.5% | 78,346 | +5.3% | 0.01% | +25.0% |
Q4 2016 | $1,138,000 | -99.9% | 74,406 | -0.3% | 0.00% | -20.0% |
Q3 2016 | $1,184,616,000 | +21.6% | 74,598 | +0.2% | 0.01% | +25.0% |
Q2 2016 | $973,878,000 | +20.7% | 74,484 | +1.0% | 0.00% | +33.3% |
Q1 2016 | $807,000,000 | -5.6% | 73,762 | 0.0% | 0.00% | -25.0% |
Q4 2015 | $855,000,000 | +110939.0% | 73,762 | -0.2% | 0.00% | +33.3% |
Q3 2015 | $770,000 | -99.9% | 73,890 | +0.1% | 0.00% | -25.0% |
Q2 2015 | $890,052,000 | -26.0% | 73,802 | -1.8% | 0.00% | -20.0% |
Q1 2015 | $1,202,224,000 | +4.4% | 75,139 | 0.0% | 0.01% | 0.0% |
Q4 2014 | $1,151,129,000 | +11.6% | 75,139 | -5.6% | 0.01% | 0.0% |
Q3 2014 | $1,031,179,000 | -13.9% | 79,597 | +1.8% | 0.01% | 0.0% |
Q2 2014 | $1,198,346,000 | +35.4% | 78,170 | +8.9% | 0.01% | +25.0% |
Q1 2014 | $884,736,000 | +23.4% | 71,813 | +16.3% | 0.00% | +33.3% |
Q4 2013 | $716,964,000 | -3.0% | 61,754 | -1.0% | 0.00% | -25.0% |
Q3 2013 | $739,132,000 | +27.8% | 62,374 | +7.3% | 0.00% | +33.3% |
Q2 2013 | $578,222,000 | – | 58,114 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $183,240,000 | 17.56% |
HealthInvest Partners AB | 1,450,000 | $16,211,000 | 12.91% |
Healthcare Value Capital, LLC | 200,000 | $2,236,000 | 4.98% |
BRIDGER MANAGEMENT, LLC | 2,852,414 | $31,890,000 | 2.98% |
Camber Capital Management LP | 7,500,000 | $83,850,000 | 2.88% |
13D Management LLC | 658,017 | $7,357,000 | 2.72% |
Brown Capital Management | 20,170,126 | $225,502,000 | 1.68% |
Healthcare Value Capital, LLC | 50,000 | $559,000 | 1.24% |
Zebra Capital Management LLC | 59,122 | $661,000 | 0.73% |
PRICE MICHAEL F | 520,000 | $5,814,000 | 0.70% |